These compounds may interact with:
Retinol-binding protein 4
Potentially involved in: microphthalmia; obesity; diabetes mellitus; fatty liver disease; matthew-wood syndrome; lipid metabolism disorder; polycystic ovary syndrome; hyperglycemia; hypertension; spontaneous abortion; patent ductus arteriosus; heart failure; kidney diseases; alcoholic liver diseases; animal mammary neoplasms; mammary neoplasms, experimental; microphthalmos; necrosis; stomach neoplasms; low vision
Disease data sourced from Pharos.